Sarah Schellhorn Mougalian, MD @SMougalian, focuses her care on patients with #breastcancer, working closely with a multidisciplinary team to address every patient's goals & treatment options. #bcsm
Read more from Dr. Mougalian https://t.co/1nNvqzQCRC @SmilowCancer@YaleMed@YNHH
Outstanding piece by my amazing colleague, Dr. Tara Sanft, on the emotions we face as physicians caring for patients at the end of life. @tarasanftmd@maryam_lustberg
https://t.co/xsusXlFiYi
Huge congratulations to our incredible director, @cpgYALE, on receiving the Yale Cancer Center Award for Mentorship Excellence! 🎉 Such a well-deserved recognition for a generous and talented mentor and collaborator! @YaleCancer@YaleMed@NCSP_Yale
.@SMougalian@YaleCancer speaks to @SUMOncology on the explosion of new FDA-approved therapies in breast cancer in the last several years cc: @MVanMeterMD#bcsm
Sequencing of treatment remains a major area of investigation
Take 2 Aspirin? How about take 2 seconds to look at data showing the impact of decades of reliance on biomedical model: persistent inequity in #cancer (& other) outcomes. https://t.co/e1WtyiYx7l Only redeeming feature of this @WSJ piece: author is FORMER dean of curriculum.